Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Digestive and liver disease 2020-02, Vol.52 (2), p.239-240
Hauptverfasser:	Patoulias, Dimitrios, Katsimardou, Alexandra, Kalogirou, Maria-Styliani, Karagiannis, Asterios, Doumas, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	Diabetes Mellitus, Type 2 Glucose Humans Hypoglycemic Agents Liver Transplantation Prevalence Sodium Sodium-Glucose Transporter 2 Inhibitors Symporters
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	240
container_issue	2
container_start_page	239
container_title	Digestive and liver disease
container_volume	52
creator	Patoulias, Dimitrios Katsimardou, Alexandra Kalogirou, Maria-Styliani Karagiannis, Asterios Doumas, Michael
description
doi_str_mv	10.1016/j.dld.2019.10.016
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2320641809</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1590865819308849</els_id><sourcerecordid>2320641809</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-120fda1543791acba91d30455e2002c9baaa52a680625797f90a6b11e77053b83</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EolD4ADbISzYuftR5iAVCFY9KldjA2nKcCXWVxsF2KvXvcZXCktWMr-9czRyEbhidMcqy-82sbusZp6xM71lSTtAFK_KCCJnx09TLkpIik8UEXYawoZSzTNJzNBEsL3Ip5QWyy4DjGjxg3e1x32oDuHEeB1fbYUu-2sG4ANg4Er3uQu98BE84tt3aVjY6H1KLexciae0OPB5tre6ijtalr1Sgi-HxCp01ug1wfaxT9Pny_LF4I6v31-XiaUWMkCISxmlTaybnIi-ZNpUuWS3oXErgaX9TVlpryXVW0IzLvMybkuqsYgzynEpRFWKK7sbc3rvvAUJUWxsMtGklcENQXHCazVlBy2Rlo9V4F4KHRvXebrXfK0bVgbDaqERYHQgfpKSkmdtj_FBtof6b-EWaDA-jAdKROwteBZMIGKitBxNV7ew_8T8lLoxn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2320641809</pqid></control><display><type>article</type><title>Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Patoulias, Dimitrios ; Katsimardou, Alexandra ; Kalogirou, Maria-Styliani ; Karagiannis, Asterios ; Doumas, Michael</creator><creatorcontrib>Patoulias, Dimitrios ; Katsimardou, Alexandra ; Kalogirou, Maria-Styliani ; Karagiannis, Asterios ; Doumas, Michael</creatorcontrib><identifier>ISSN: 1590-8658</identifier><identifier>EISSN: 1878-3562</identifier><identifier>DOI: 10.1016/j.dld.2019.10.016</identifier><identifier>PMID: 31787555</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Diabetes Mellitus, Type 2 ; Glucose ; Humans ; Hypoglycemic Agents ; Liver Transplantation ; Prevalence ; Sodium ; Sodium-Glucose Transporter 2 Inhibitors ; Symporters</subject><ispartof>Digestive and liver disease, 2020-02, Vol.52 (2), p.239-240</ispartof><rights>2019 Editrice Gastroenterologica Italiana S.r.l.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-120fda1543791acba91d30455e2002c9baaa52a680625797f90a6b11e77053b83</citedby><cites>FETCH-LOGICAL-c353t-120fda1543791acba91d30455e2002c9baaa52a680625797f90a6b11e77053b83</cites><orcidid>0000-0002-6899-684X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.dld.2019.10.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31787555$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Patoulias, Dimitrios</creatorcontrib><creatorcontrib>Katsimardou, Alexandra</creatorcontrib><creatorcontrib>Kalogirou, Maria-Styliani</creatorcontrib><creatorcontrib>Karagiannis, Asterios</creatorcontrib><creatorcontrib>Doumas, Michael</creatorcontrib><title>Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?</title><title>Digestive and liver disease</title><addtitle>Dig Liver Dis</addtitle><subject>Diabetes Mellitus, Type 2</subject><subject>Glucose</subject><subject>Humans</subject><subject>Hypoglycemic Agents</subject><subject>Liver Transplantation</subject><subject>Prevalence</subject><subject>Sodium</subject><subject>Sodium-Glucose Transporter 2 Inhibitors</subject><subject>Symporters</subject><issn>1590-8658</issn><issn>1878-3562</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0EolD4ADbISzYuftR5iAVCFY9KldjA2nKcCXWVxsF2KvXvcZXCktWMr-9czRyEbhidMcqy-82sbusZp6xM71lSTtAFK_KCCJnx09TLkpIik8UEXYawoZSzTNJzNBEsL3Ip5QWyy4DjGjxg3e1x32oDuHEeB1fbYUu-2sG4ANg4Er3uQu98BE84tt3aVjY6H1KLexciae0OPB5tre6ijtalr1Sgi-HxCp01ug1wfaxT9Pny_LF4I6v31-XiaUWMkCISxmlTaybnIi-ZNpUuWS3oXErgaX9TVlpryXVW0IzLvMybkuqsYgzynEpRFWKK7sbc3rvvAUJUWxsMtGklcENQXHCazVlBy2Rlo9V4F4KHRvXebrXfK0bVgbDaqERYHQgfpKSkmdtj_FBtof6b-EWaDA-jAdKROwteBZMIGKitBxNV7ew_8T8lLoxn</recordid><startdate>202002</startdate><enddate>202002</enddate><creator>Patoulias, Dimitrios</creator><creator>Katsimardou, Alexandra</creator><creator>Kalogirou, Maria-Styliani</creator><creator>Karagiannis, Asterios</creator><creator>Doumas, Michael</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6899-684X</orcidid></search><sort><creationdate>202002</creationdate><title>Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?</title><author>Patoulias, Dimitrios ; Katsimardou, Alexandra ; Kalogirou, Maria-Styliani ; Karagiannis, Asterios ; Doumas, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-120fda1543791acba91d30455e2002c9baaa52a680625797f90a6b11e77053b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Diabetes Mellitus, Type 2</topic><topic>Glucose</topic><topic>Humans</topic><topic>Hypoglycemic Agents</topic><topic>Liver Transplantation</topic><topic>Prevalence</topic><topic>Sodium</topic><topic>Sodium-Glucose Transporter 2 Inhibitors</topic><topic>Symporters</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Patoulias, Dimitrios</creatorcontrib><creatorcontrib>Katsimardou, Alexandra</creatorcontrib><creatorcontrib>Kalogirou, Maria-Styliani</creatorcontrib><creatorcontrib>Karagiannis, Asterios</creatorcontrib><creatorcontrib>Doumas, Michael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive and liver disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patoulias, Dimitrios</au><au>Katsimardou, Alexandra</au><au>Kalogirou, Maria-Styliani</au><au>Karagiannis, Asterios</au><au>Doumas, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?</atitle><jtitle>Digestive and liver disease</jtitle><addtitle>Dig Liver Dis</addtitle><date>2020-02</date><risdate>2020</risdate><volume>52</volume><issue>2</issue><spage>239</spage><epage>240</epage><pages>239-240</pages><issn>1590-8658</issn><eissn>1878-3562</eissn><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>31787555</pmid><doi>10.1016/j.dld.2019.10.016</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-6899-684X</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 1590-8658
ispartof	Digestive and liver disease, 2020-02, Vol.52 (2), p.239-240
issn	1590-8658 1878-3562
language	eng
recordid	cdi_proquest_miscellaneous_2320641809
source	MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects	Diabetes Mellitus, Type 2 Glucose Humans Hypoglycemic Agents Liver Transplantation Prevalence Sodium Sodium-Glucose Transporter 2 Inhibitors Symporters
title	Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T15%3A51%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20there%20any%20place%20for%20sodium-glucose%20co-transporter-2%20inhibitors%20in%20post-liver%20transplantation%20patients?&rft.jtitle=Digestive%20and%20liver%20disease&rft.au=Patoulias,%20Dimitrios&rft.date=2020-02&rft.volume=52&rft.issue=2&rft.spage=239&rft.epage=240&rft.pages=239-240&rft.issn=1590-8658&rft.eissn=1878-3562&rft_id=info:doi/10.1016/j.dld.2019.10.016&rft_dat=%3Cproquest_cross%3E2320641809%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2320641809&rft_id=info:pmid/31787555&rft_els_id=S1590865819308849&rfr_iscdi=true